Abstract
Cost-effectiveness analyses (CEA) are important in healthcare decision-making and resource allocation for assessing costs and benefits of new treatments in terms of clinical efficiency. Expanding value elements, such as health equity, for new technologies in traditional CEAs has attracted interest. This study synthesized evidence on how equity concepts were considered in modified CEAs by conducting an umbrella review of systematic literature reviews (SLR).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
